Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Gilleaudeau

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
The Nursing Clinics of North America|September 11, 2007
Psoriasis: hope for the futureMary Sullivan-Whalen, Patricia Gilleaudeau
BMC Dermatology|April 2, 2010
Differing effect of systemic anti psoriasis therapies on platelet physiology--a case report and review of literatureBatya B Davidovici, Mary M Sullivan-Whalen, Patricia Gilleaudeau, et al.
The Journal of Allergy and Clinical Immunology|February 6, 2021
Epithelialized tunnels are a source of inflammation in hidradenitis suppurativaKristina Navrazhina, John W Frew, Patricia Gilleaudeau, et al.
Archives of Dermatology|February 18, 2003
Narrowband (312-nm) UV-B suppresses interferon gamma and interleukin (IL) 12 and increases IL-4 transcripts: differential regulation of cytokines at the single-cell levelIan B Walters, Maki Ozawa, Irma Cardinale, et al.
The Journal of Investigative Dermatology|June 18, 2010
Effective narrow-band UVB radiation therapy suppresses the IL-23/IL-17 axis in normalized psoriasis plaquesLeanne M Johnson-Huang, Mayte Suárez-Fariñas, Mary Sullivan-Whalen, et al.
Journal of the American Academy of Dermatology|May 17, 2020
The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: An open-label cohort studyJohn W Frew, Kristina Navrazhina, David Grand, et al.
The Journal of Investigative Dermatology|July 6, 2016
Molecular Profiling of Immune Activation Associated with Regression of Melanoma Metastases Induced by DiphencyproneNicholas Gulati, Sandra Garcet, Judilyn Fuentes-Duculan, et al.
Clinical Immunology (Orlando, Fla.)|September 24, 2004
Efalizumab (anti-CD11a)-induced increase in peripheral blood leukocytes in psoriasis patients is preferentially mediated by altered trafficking of memory CD8+ T cells into lesional skinYulia Vugmeyster, Toyoko Kikuchi, Michelle A Lowes, et al.
Experimental Dermatology|October 17, 2018
Novel immune signatures associated with dysplastic naevi and primary cutaneous melanoma in human skinBernice Y Yan, Sandra Garcet, Nicholas Gulati, et al.
The Journal of Investigative Dermatology|April 23, 2014
Molecular characterization of human skin response to diphencyprone at peak and resolution phases: therapeutic insightsNicholas Gulati, Mayte Suárez-Fariñas, Judilyn Fuentes-Duculan, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
The Nursing Clinics of North America|September 11, 2007
Psoriasis: hope for the futureMary Sullivan-Whalen, Patricia Gilleaudeau
BMC Dermatology|April 2, 2010
Differing effect of systemic anti psoriasis therapies on platelet physiology--a case report and review of literatureBatya B Davidovici, Mary M Sullivan-Whalen, Patricia Gilleaudeau, et al.
The Journal of Allergy and Clinical Immunology|February 6, 2021
Epithelialized tunnels are a source of inflammation in hidradenitis suppurativaKristina Navrazhina, John W Frew, Patricia Gilleaudeau, et al.
Archives of Dermatology|February 18, 2003
Narrowband (312-nm) UV-B suppresses interferon gamma and interleukin (IL) 12 and increases IL-4 transcripts: differential regulation of cytokines at the single-cell levelIan B Walters, Maki Ozawa, Irma Cardinale, et al.
The Journal of Investigative Dermatology|June 18, 2010
Effective narrow-band UVB radiation therapy suppresses the IL-23/IL-17 axis in normalized psoriasis plaquesLeanne M Johnson-Huang, Mayte Suárez-Fariñas, Mary Sullivan-Whalen, et al.
Journal of the American Academy of Dermatology|May 17, 2020
The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: An open-label cohort studyJohn W Frew, Kristina Navrazhina, David Grand, et al.
The Journal of Investigative Dermatology|July 6, 2016
Molecular Profiling of Immune Activation Associated with Regression of Melanoma Metastases Induced by DiphencyproneNicholas Gulati, Sandra Garcet, Judilyn Fuentes-Duculan, et al.
Clinical Immunology (Orlando, Fla.)|September 24, 2004
Efalizumab (anti-CD11a)-induced increase in peripheral blood leukocytes in psoriasis patients is preferentially mediated by altered trafficking of memory CD8+ T cells into lesional skinYulia Vugmeyster, Toyoko Kikuchi, Michelle A Lowes, et al.
Experimental Dermatology|October 17, 2018
Novel immune signatures associated with dysplastic naevi and primary cutaneous melanoma in human skinBernice Y Yan, Sandra Garcet, Nicholas Gulati, et al.
The Journal of Investigative Dermatology|April 23, 2014
Molecular characterization of human skin response to diphencyprone at peak and resolution phases: therapeutic insightsNicholas Gulati, Mayte Suárez-Fariñas, Judilyn Fuentes-Duculan, et al.
Pageof 4